Document is current
Any future updates will be listed below
-
Authors
Peoples, Anita R.
Obón-Santacana, Mireia
Kim, Andre E.
Kawaguchi, Eric S.
Fu, Yubo
Qu, Conghui
Moratalla-Navarro, Ferran
Morrison, John
Lin, Yi
Arndt, Volker
Berndt, Sonja I.
Bien, Stephanie A.
Bishop, D. Timothy
Bouras, Emmanouil
Brenner, Hermann
Buchanan, Daniel D.
Campbell, Peter T.
Chan, Andrew T.
Chang-Claude, Jenny
Conti, David V.
Corley, Douglas AC.
Devall, Matthew A.
Dimou, Niki
Drew, David A.
Gruber, Stephen B.
Gunter, Marc J.
Harlid, Sophia
Harrison, Tabitha A.
Hoffmeister, Michael
Hsu, Li
Huyghe, Jeroen R.
Keku, Temitope O.
Kundaje, Anshul
Lewinger, Juan Pablo
Li, Li
Lynch, Brigid M.
Le Marchand, Loic
Martín, Vicente
Murphy, Neil
Newton, Christina C.
Ogino, Shuji
Hardikar, Sheetal
Ose, Jennifer
Pai, Rish K.
Palmer, Julie R.
Papadimitriou, Nikos
Pardamean, Bens
Pellatt, Andrew J.
Pinchev, Mila
Platz, Elizabeth A.
Potter, John D.
Rennert, Gad
Ruiz-Narvaez, Edward A.
Sakoda, Lori C.
Schoen, Robert E.
Shcherbina, Anna
Stern, Mariana C.
Su, Yu-Ru
Thomas, Claire E.
Tian, Yu
Tsilidis, Konstantinos K.
Um, Caroline Y.
van Duijnhoven, Franzel J. B.
Van Guelpen, Bethany
Visvanathan, Kala
Wang, Jun
White, Emily
Wolk, Alicja
Woods, Michael O.
Wu, Anna H.
Ulrich, Cornelia M.
Peters, Ulrike
Gauderman, W. James
Moreno, Victor
-
Funding
Funding for this research was provided by:
National Cancer Institute (R21 CA191312)
National Cancer Institute (R01 CA248857)
National Cancer Institute (U01 CA137088, R01 CA059045, U01 CA164930, R01 CA201407, R01 CA244588)
National Cancer Institute (R01 CA273198)
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 29 January 2026
First Online: 5 February 2026
Declarations
:
: The study was conducted in accordance with the principles of the Declaration of Helsinki; each contributing study was approved by its respective Institutional Review Board or relevant research committee. For CPS-II, written informed consent was received from participants to obtain medical records. At the time of each mailed survey, participants were informed that their identifying information would be used to link with cancer registries and death indexes. For the other studies, all study participants provided informed consent.
: Not applicable.
: Dr. Ulrich has as HCI Cancer Center Director oversight over research funded by several pharmaceutical companies but has not received funding directly herself. Dr. Peters was a consultant with AbbVie and her husband is holding individual stocks for the following companies: BioNTech SE – ADR, Amazon, CureVac BV, NanoString Technologies, Google/Alphabet Inc Class C, NVIDIA Corp, Microsoft Corp. Other authors declare that they have no conflict of interest.
